SCHEMBL28045432

SCHEMBL28045432

O=C(O)Nc1ccnc(C(=O)N2CCOCC2)c1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ RAB9A P51151 6/20 0.45
▸ NPC1 O15118 5/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C9 P11712 1/20 0.44
▸ CYP2C19 P33261 1/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ PIK3C3 Q8NEB9 1/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ GAA P10253 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ LRRK2 Q5S007 1/20 0.43
▸ TP53 P04637 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ TP53BP1 Q12888 1/20 0.42
▸ MEN1 O00255 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2439976 0.83 SMN1; SMN2 (0.47) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL2439973 0.83 RAB9A (0.47) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL15971808 0.82 PRKDC (0.46) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL15223500 0.80 RAB9A (0.56) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL28872983 0.80 SMN1; SMN2 (0.63) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL28296111 0.78 ALDH1A1 (0.52) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL3439414 0.77 RAB9A (0.56) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL29417566 0.77 SMN1; SMN2 (0.52) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL11918962 0.77 SMN1; SMN2 (0.49) SMN1; SMN2RAB9ANPC1ALDH1A1CYP1A2
SCHEMBL28292635 0.75 SCN10A (0.44) ALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105189480-A Pyrimidine compounds useful in the treatment of disorders mediated by the IKK and/or TBK-1 mechanism DOMAINEX LTD 2015-12-23 — — CN disclosed
Send feedback